Showing results (121-130 of 135) with videos related to
Sort By:
Pageof 14
Oncotarget|October 21, 2014
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumorsGideon M Blumenthal, Joell J Gills, Marc S Ballas, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2022
Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-AnalysisElinor Zhou, Lin Wang, Celina N Santiago, et al.Gut Microbes|January 18, 2025
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohortJulia L Drewes, Samara B Rifkin, Madison McMann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivoJoell J Gills, Jaclyn Lopiccolo, Junji Tsurutani, et al.The British Journal of Nutrition|February 21, 2020
Yogurt consumption and colorectal polypsSamara B Rifkin, Francis M Giardiello, Xiangzhu Zhu, et al.American Journal of Surgery|May 9, 2022
Presentation, clinical course and complications in trauma patients with concomitant COVID-19 infectionC H Meyer, A Grant, Richard Sola, et al.Planta Medica|August 25, 2004
Natural inhibitors of carcinogenesisA Douglas Kinghorn, Bao-Ning Su, Dae Sik Jang, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2026
Racial, ethnic and sex-specific mechanisms of obstructive sleep apnea and Alzheimer's disease riskKomal Patel Murali, Joshua Gills, Arlener Turner, et al.Cancer Immunology, Immunotherapy : CII|February 26, 2022
Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitorsFyza Y Shaikh, Joell J Gills, Fuad Mohammad, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Primary resistance to ICI-based regimens is associated with early longitudinal changes in the fecal microbiome and loss of microbial stabilityYujie Zhao, Jarushka Naidoo, Michael Conroy, et al.Pageof 14